Scholarly publications and presentations by Rochester Regional Health's Oncology and Hematology department authors.
Submissions from 2018
8-24-2018 Cirrhosis in Hemochromatosis: Independent Risk Factors in 368 HFE p.C282Y Homozygotes, James C. Barton, Christine E. McLaren, Department of Epidemiology, University of California, Irvine, CA, USA., Wen-Pin Chen, Chao Family Comprehensive Cancer Center, Irvine, CA, USA., et al.
2-1-2018 Racial Differences in Information Needs During and After Cancer Treatment: a Nationwide, Longitudinal Survey by the University of Rochester Cancer Center National Cancer Institute Community Oncology Research Program, Matthew Asare, University of Rochester Medical Center, Luke J Peppone, University of Rochester Medical Center, Joseph A. Roscoe, University of Rochester Medical Center, et al.
Submissions from 2017
3-1-2017 GNPAT p.D519G is independently associated with markedly increased iron stores in HFE p.C282Y homozygotes, James C. Barton, Southern Iron Disorders Center, Birmingham, AL, 35209, USA; Department of Medicine, University of Alabama at Birmingham, Birmingham, AL 35294, USA., Wen-Pin Chen, Chao Family Comprehensive Cancer Center, Irvine, CA 92697, USA., Mary J. Emond, Department of Biostatistics, University of Washington, Seattle, WA 98195, USA., et al.
3-1-2017 Reply to HEP 16-0784.R1 and HEP 16-0898, Gordon D. McLaren, Department of Veterans Affairs Long Beach Healthcare System, Long Beach, CA., James C. Barton, Southern Iron Disorders Center, Birmingham, AL., Grant A. Ramm, QIMR Berghofer Medical Research Institute, Brisbane, Australia., et al.
1-2-2017 Decision points in the treatment of transfusional iron overload in patients with myelodysplastic syndromes: why, when, and how to chelate, Farhan Imran, Rochester Regional Health and Pradyumna Phatak, Rochester Regional Health
Submissions from 2016
11-1-2016 Outpatient administration of BEAM conditioning prior to autologous stem cell transplantation for lymphoma is safe, feasible, and cost-effective, Robin M. Reid, Rochester Regional Health, Andrea Baran, James P Wilmot Cancer Institute and Department of Medicine, University of Rochester Medical Center, Rochester, New York., Jonathan W. Friedberg, James P Wilmot Cancer Institute and Department of Medicine, University of Rochester Medical Center, Rochester, New York., et al.
6-1-2016 Reply, Christine E. McLaren, Department of Epidemiology, University of California, Irvine, CA., James C. Barton, Southern Iron Disorders Center, Birmingham, AL., Pradyumna D. Phatak, Rochester Regional Health, et al.
6-1-2016 Reply, Christine E. McLaren, Department of Epidemiology, University of California, Irvine, CA., James C. Barton, Southern Iron Disorders Center, Birmingham, AL., V Nathan Subramaniam, QIMR Berghofer Medical Research Institute, Brisbane, Australia., et al.
3-1-2016 Buspirone for management of dyspnea in cancer patients receiving chemotherapy: a randomized placebo-controlled URCC CCOP study, Anita R. Peoples, University of Rochester Cancer Center Community Clinical Oncology Program Research Base, Behavioral Medicine Unit, University of Rochester Medical Center, 265 Crittenden Blvd., CU 420658, Rochester, NY, 14642, USA, Peter W. Bushunow, Rochester Regional Health, Sheila N. Garland, Department of Family Medicine and Community Health, University of Pennsylvania, Philadelphia, PA, USA., et al.
1-27-2016 Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: A pilot randomized clinical trial, Saad Jamshed, Rochester Regional Health, Edward E. Walsh, Rochester Regional Health, Lynda J. Dimitroff, Nazareth College, Department of Nursing, 4245 East Avenue, Rochester, NY 14618, USA, et al.
Submissions from 2015
7-1-2015 Dismissal of the Noncompliant Patient: Is This What We Have Come To?, Evelyn I. Stelmach, Rochester Regional Health
2-1-2015 Prevention of venous thromboembolism in cancer outpatients: Guidance from the SSC of the ISTH: Reply, A. A. Khorana, Taussig Cancer Center, J. I. Zwicker, Harvard Medical School, Greg C. Connolly, Rochester Regional Health, et al.